| Synonyms: | |
| Status: | Phase 3 |
| Entry Type: | Small molecule |
| Molecule Category: | UNKNOWN |
| ATC: | S01EB05 |
| UNII: | 9U1VM840SP |
| InChI Key | PIJVFDBKTWXHHD-HIFRSBDPSA-N |
|---|---|
| Smile | |
| InChI |
|
| Property Name | Value |
|---|---|
| Molecular Formula | C15H21N3O2 |
| Molecular Weight | 275.35 |
| AlogP | 1.77 |
| Hydrogen Bond Acceptor | 4.0 |
| Hydrogen Bond Donor | 1.0 |
| Number of Rotational Bond | 1.0 |
| Polar Surface Area | 44.81 |
| Molecular species | NEUTRAL |
| Aromatic Rings | 1.0 |
| Heavy Atoms | 20.0 |
| Primary Target | |
|---|---|
| acetylcholinesterase (Cartwright blood group) |
| Targets | EC50(nM) | IC50(nM) | Kd(nM) | Ki(nM) | Inhibition(%) | |
|---|---|---|---|---|---|---|
|
Enzyme
Hydrolase
|
- | 0-25000 | - | 34-1000 | 8-100 | |
|
Membrane receptor
Family A G protein-coupled receptor
Small molecule receptor (family A GPCR)
Monoamine receptor
Acetylcholine receptor
|
- | 37000-37000 | - | - | - | |
|
Transporter
Electrochemical transporter
SLC superfamily of solute carriers
SLC21/SLCO family of organic anion transporting polypeptides
|
- | - | - | - | 78 |
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Pain | 3 | D010146 | ClinicalTrials |
| Delirium | 3 | D003693 | ClinicalTrials |
| Insulin Resistance | 0 | D007333 | ClinicalTrials |
| Resources | Reference |
|---|---|
| CAS NUMBER | 57-47-6 |
| ChEBI | 27953 |
| ChEMBL | CHEMBL94 |
| DrugBank | DB00981 |
| DrugCentral | 2159 |
| EPA CompTox | DTXSID3023471 |
| FDA SRS | 9U1VM840SP |
| Human Metabolome Database | HMDB0015116 |
| Guide to Pharmacology | 6598 |
| KEGG | C06535 |
| PharmGKB | PA450957 |
| PubChem | 5983 |
| SureChEMBL | SCHEMBL24044 |
| ZINC | ZINC000091689892 |